Platelet Aging In Vivo Is Associated with Loss of Membrane Phospholipid Asymmetry

Summary

The mechanism(s) involved in the clearance of senescent platelets are largely unknown. The loss of membrane phospholipid (PL) asymmetry, with phosphatidylserine (PS) exposure appears to be an important signal for the ingestion by macrophages of apoptotic nucleated cells and it has also been suggested as a signal for the removal of aged erythrocytes. Accordingly, it seems possible that the clearance of normal aged platelets from circulation might be triggered by PS exposure. To investigate this, we determined PS exposure in human aging platelets taking advantage of the relationship between platelet density and platelet age and in dog platelets in a model of platelet aging in vivo. PS exposure was determined in two experimental conditions: 1) human platelet density subpopulations obtained by centrifugation in arabinogalactan gradients; 2) circulating canine platelets during decline in platelet count after suppression of thrombopoiesis following estradiol injection. PS exposure was determined by flow cytometry after labeling the cells with FITC-conjugated annexin V. The proportion of human platelets with exposed PS was significantly higher in high density (HD) platelets compared to low density (LD) platelets (11.3 ± 8.0% vs 5.2 ± 3.7%; p <0.05, respectively). In dogs, the proportion of cells with exposed PS rises dramatically with age, from 3.1 ± 0.4% before to 17.7 ± 12.3% ten days after estradiol injection. These findings suggest that platelet aging is associated with loss of phospholipid asymmetry and PS exposure on the outer leaflet of cell membrane, which may play an important role in the recognition and subsequent removal of senescent platelets.

Key Words

Platelet age - phosphatidylserine - platelet removal

• References

• 1 George JN, Dale GL. Platelet kinetics. In: Hematology. Beutler E, Lichtman MA, Coller BS, Kipps TJ. eds. New York: McGraw-Hill Inc; 1995: 1202-5.
• 2 Mezzano D, Hwang KL, Catalano P, Aster RH. Evidence that platelet buoyant density, but not size, correlates with platelet age in man. Am J Hematol 1981; 11: 61-76.
• 3 Boneu B, Vigoni F, Boneu A, Caranobe C, Sie P. Further studies on the relationship between platelet buoyant density and platelet age. Am J Hematol 1982; 13: 239-46.
• 4 Mezzano D, Aranda E, Rodríguez S, Foradori A, Lira P. Increase in density and accumulation of serotonin by human aging platelets. Am J Hematol 1984; 17: 11-21.
• 5 Martin JF, Penington DG. The relationship between the age and density of circulating ⁵¹ Cr-labeled platelets in the subhuman primate. Thromb Res 1983; 30: 157-64.
• 6 Karpatkin S. Heterogeneity of rabbit platelets VI. Further resolution of changes in platelet density, volume, and radioactivity following cohort labeling with ⁷⁵ Se-seleniomethionine. Br J Haematol 1978; 39: 459-69.
• 7 Corash L, Costa JL, Shafer B, Donlon JA, Murphy D. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 1984; 64: 185-193.
• 8 Packham MA, Guccione MA, O’Brien KM. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated by thrombin. Blood 1985; 66: 287-90.
• 9 Mezzano D, Aranda E, Foradori A, Rodríguez S, Lira P. Kinetics of platelet density subpopulations in splenectomized mongrel dogs. Am J Hematol 1984; 17: 373-82.
• 10 Mishory B, Danon D. Structural aspects of in vivo aging rabbit blood platelets. Thromb Res 1978; 12: 893-906.
• 11 Mezzano D, Aranda E, Foradori A. Comparative study of size, total protein, fibrinogen and 5-HT content of human and canine platelet density subpopulations. Thromb Haemost 1986; 56: 288-92.
• 12 Kelton JG, Denomme G. The quantitation of platelet-associated IgG on cohorts of platelets separated from healthy individuals by buoyant density centrifugation. Blood 1982; 60: 136-9.
• 13 Pfueller SL, Chesterman C, Illes I, Hussein S, Martin JF. Relationship of platelet-associated immunoglobulin G and platelet protein to platelet size and density in normal individuals and patients with thrombocytopenia. J Lab Clin Med 1986; 107: 299-305.
• 14 Pereira J, Cretney C, Aster RH. Variation of class I HLA antigen expression among platelet density cohorts: A possible index of platelet age?. Blood 1988; 71: 516-9.
• 15 Aranda E, Pereira J, Ajenjo C, Prieto C, Sepúlveda S, Mezzano D. Human intraplatelet 5-hydroxytryptamine is correlated with mean platelet survival time. Thromb Res 1996; 84: 67-72.
• 16 Aranda E, Pizarro M, Pereira J, Mezzano D. Accumulation of 5-hydroxy-tryptamine by aging platelets: studies in a model of supressed thrombopoiesis in dogs. Thromb Haemost 1994; 71: 488-92.
• 17 Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, VanSchie RCAA, Laface DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and abl. J Exp Med 1995; 182: 1545-56.
• 18 Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
• 19 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
• 20 Blumenfeld N, Zachowski A, Galacteros F, Beuzard Y, Devaux PF. Transmembrane mobility of phospholipids in sickle erythrocytes: effect of de-oxygenation on diffusion and asymmetry. Blood 1991; 77: 849-54.
• 21 Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells: Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994; 269: 2399-404.
• 22 Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human monocytes. Cancer Res 1991; 51: 3062-6.
• 23 Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-35.
• 24 Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131-6.
• 25 Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometric study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-65.
• 26 Vanags DM, Orrenius S, Aguilar-Santelices M. Alterations in Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis. Br J Haematol 1997; 99: 824-31.
• 27 Chiu T. Studies on estrogen-induced proliferative disorders of hemopoietic tissue in dogs. St. Paul: University of Minnesota. Ph. D. Thesis 1974: 1-270.
• 28 Kumar A, Kumar A, Deepika K, Fernández J, Eisdorfer C. A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindolacetic acid in cerebrospinal fluid, platelet and plasma. Life Sciences 1990; 47: 1751-9.
• 29 Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996; 236: 1-26.
• 30 Tonon G, Luo X, Chen W, Shi Y, Greco N, Cattaneo M, Jamieson GA. Expression of apoptotic markers in activated platelets is mediated in part by cathepsin. Blood 1998; 92: 30a.
• 31 Berger G, Hartwell DW, Wagner DD. Platelet death. An apoptotic like process?. Blood 1998; 92: 347a.
• 32 Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1366: 151-65.